AI + EXCLUSIVE DATA

AI tracks executive moves from sources others don't have

Our proprietary AI analyzes exclusive hiring data to find decision-makers actively evaluating solutions like yours.

10-25 executive leads daily • Direct contact info • First 90 days targeting

Start with:

✓Flexible Plans • $39/mo or $29/mo annual

✓AI + proprietary hiring database

✓Executive contact details included

INDUSTRY FIRST

Koru Medical Systems, Inc. Names Andrew La Frence As Chief Financial Officer

Jun 27, 2023•about 2 years ago

Position

Chief Financial Officer

Company

KORU Medical Systems

Andrew LaFrence

MahwahMedical DeviceBiotechnologyHealth CareManufacturing

Description

KORU Medical Systems, Inc. , a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and easy-to-use specialty subcutaneous infusion solutions that improve quality of life for patients, today announced the appointment of Andrew D. C

Company Information

Company

KORU Medical Systems

Location

Mahwah, New Jersey, United States

About

KORU Medical Systems develops, manufactures, and commercializes innovative and patient-centric large volume subcutaneous infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System (the “Freedom System”) currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. The Freedom System, which received its first FDA clearance in 1994, is used for self-administration in the home by the patient and/or delivery in an ambulatory infusion center by a healthcare professional. Through its Novel Therapies business, KORU Medical provides products for use by biopharmaceutical companies in feasibility/clinical trials during the drug development process and, as needed, is capable of customizing the Freedom System for clinical and commercial use across multiple drug categories.

Company News

(9 articles)

Wed, 16 Apr 2025 07:00:00 GMT

KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025 - Business Wire

Wed, 30 Jul 2025 20:05:00 GMT

KORU Medical Systems Reveals Growth Strategy at Major Canaccord Conference - Live Webcast Available - Stock Titan

Wed, 12 Mar 2025 07:00:00 GMT

KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance - Business Wire

Thu, 30 Jan 2025 08:00:00 GMT

KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology - Business Wire

Wed, 23 Oct 2019 07:00:00 GMT

RMS Medical rebrands as Koru Medical Systems - MassDevice

Mon, 07 Jul 2025 07:00:00 GMT

KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer - Business Wire

Wed, 11 Jun 2025 07:00:00 GMT

KORU Medical Systems to Join Russell 3000® and Russell 2000® Indexes - Business Wire

Wed, 07 May 2025 07:00:00 GMT

KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance - Business Wire

Tue, 04 Jun 2024 07:00:00 GMT

KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic - Business Wire

FundzWatch™ Score

Medium Activity

Related People

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months